Here's what macular degeneration is, what causes it and how you can expect it to be treated if it affects you or a loved one.

Several clinical trials are being conducted to evaluate additional novel agents to treat age-related macular degeneration.

Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...

Examining the performance of AI algorithms versus human graders in neovascular age-related macular degeneration ...

This has been shown to delay the vision changes associated with all types of macular degeneration. Unfortunately, aging and family history are risk factors out of our control. Wet macular ...

Wet AMD treatments can be costly, but Medicare covers some options. Knowing what Medicare covers and what it doesn’t can help you choose the best treatments for your budget. Age-related macular ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Regeneron Pharmaceuticals announced positive three-year results from an extension study of EYLEA HD (aflibercept) Injection 8 mg for treating wet age-related macular degeneration (wAMD).

It is characterized by the macular gradually getting thinner with age. "Wet AMD is less common, but affects sight much quicker," says Patel. It occurs when abnormal blood vessels grow in the back ...

Macular degeneration is a condition that affects the retina, which is neural tissue that lines the back of the eye, like wallpaper in a room. There is an important area ...